Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, announced a strategic partnership with the Accelerated Cure Project (ACP), a nonprofit organization dedicated to accelerating research and improving outcomes for people with multiple sclerosis (MS). The partnership aims to develop next-generation AI models capable of predicting disease...
Platform built in collaboration with Amazon Web Services, Modus Create to produce unmatched accuracy, efficiencies and compliance for life science companies
EVERSANA, a leading provider of commercial services to the life sciences industry, announced the next milestone in its journey to transform and innovate commercialization with the launch of EVERSANA...
Agilisium – a leading Data Innovation & Agentic AI partner for the Life Sciences industry, unveiled its domain-trained Insight Generation Agent, designed to unlock insight-led decisions across the spectrum of the life sciences value chain.
This Insights Generation AI Agent is not a one-size-fits-all platform—it's a configurable intelligence layer purpose-built to address...
The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster.
Precision for Medicine, a leading provider of drug development and commercialization services, announced a strategic partnership with SOPHiA GENETICS to enhance its biomarker discovery and precision medicine services. As...
Flatiron Health, a healthtech company transforming clinical research through technology that integrates research into everyday care, announced a strategic partnership with Massive Bio, global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials, to expand patient identification capabilities and improve clinical trial enrollment across...
Xaira is an integrated biotechnology company built to deliver on the promise of artificial intelligence to help transform drug discovery and development
Xaira Therapeutics announced the appointment of Dr. Bo Wang as SVP and Head of Biomedical AI. In this role, Dr. Wang will lead the company’s efforts to develop AI-driven...
Plex Research, a biotechnology company using autonomous artificial intelligence (AI) to aid in drug discovery, announced that it is partnering with Ginkgo Datapoints, a service of Ginkgo Bioworks, to use the Plex AI Platform to deepen the understanding of compound treatment mechanisms of action, potentially revealing new therapeutic applications,...
Acquisition is another milestone of Siemens' ONE Tech Company program expanding the Siemens Xcelerator platform into Life Sciences software with stronger customers focus, faster innovations and higher growth
Siemens AG announces that it has signed an agreement to acquire Dotmatics, a leading provider of Life Sciences R&D software based in Boston, for $5.1...
Causaly announced new scientific AI agents that provide research teams with the industry's most comprehensive biomedical knowledge for drug discovery. With agentic AI in Causaly Discover, life sciences teams can access, analyze, and synthesize information across the Causaly Knowledge Graph and internal and external data sources. Now researchers can tap into...
Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing...
